4//SEC Filing
Fruchtman Steven M 4
Accession 0001415889-24-008141
CIK 0001130598other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:36 PM ET
Size
8.7 KB
Accession
0001415889-24-008141
Insider Transaction Report
Form 4
Fruchtman Steven M
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-03-14$0.90/sh−8,727$7,854→ 74,792 total - Exercise/Conversion
Restricted Stock Units
2024-03-13−23,111→ 46,222 total→ Common Stock (23,111 underlying) - Exercise/Conversion
Common Stock
2024-03-13+23,111→ 83,519 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001631251
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 5:36 PM ET
- Size
- 8.7 KB